Placebo of Aliskiren

DRUG2 trials

Sponsors

Novartis

Conditions

Abdominal ObesityEssential HypertensionHypertension

Phase 2

Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With Hypertension

TerminatedNCT00498433

NovartisAbdominal Obesity, Hypertension

Start: 2007-06-30End: 2012-03-31Updated: 2014-09-10

Phase 3

Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension

CompletedNCT01237223

NovartisEssential Hypertension

Start: 2010-10-31End: 2011-05-31Updated: 2012-06-13